[1]
Quaglia, F.M., Rigolin, G.M., Saccenti, E., Negrini, M., Volta, E., Dabusti, M., Ciccone, M., Urso, A., Laudisi, M. and Cuneo, A. 2019. Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Aug. 2019), e2019057. DOI:https://doi.org/10.4084/mjhid.2019.057.